Do MMPI-3 Validity Scale Findings Generalize to Concurrently Administered Measures? Validation with a Forensic Disability Sample
Archives of Clinical Neuropsychology · 2025
DOI: 10.1093/arclin/acae093 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Archives of Clinical Neuropsychology, 2025. Verfasst von Kaci F Holmes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychological Sciences, Kent State University 600 Hilltop Drive, Kent, OH, United States. Hauptthemen laut MEDLINE: MMPI, Persons with Disabilities. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: University of Minnesota Press.
Abstract (Originalsprache)
Objective
Research has demonstrated that over-reporting and under-reporting, when detected by the MMPI-2/-RF Validity Scales, generalize to responses to other self-report measures. The purpose of this study was to investigate whether the same is true for the Minnesota Multiphasic Personality Inventory–3 (MMPI-3) Validity Scales. We examined the generalizability of over-reporting and under-reporting detected by MMPI-3 Validity Scales to extra-test self-report, performance-based, and performance validity measures.
Method
The sample included 665 majority White, male disability claimants who, in addition to the MMPI-3, were administered several self-report measures, some with embedded symptom validity tests (SVTs), performance-based measures, and performance validity tests (PVTs). Three groups were identified based on MMPI-3 Validity Scale scores as over-reporting (n = 276), under-reporting (n = 100), or scoring within normal limits (WNL; n = 289).
Results
Over-reporting on the MMPI-3 generalized to symptom over-reporting on concurrently administered self-report measures of psychopathology and was associated with evidence of over-reporting from other embedded SVTs. It was also associated with poorer performance on concurrently administered measures of cognitive functioning and PVTs. Under-reporting on the MMPI-3 generalized to symptom minimization on collateral measures of psychopathology. On measures of cognitive functioning, we found no differences between the under-reporting and WNL groups, except for the Wisconsin Card Sorting Test–64 Card Version and Wide Range Achievement Test–Fifth Edition (each with negligible effect sizes).
Conclusions
MMPI-3 Validity Scales can identify possible over- and under-reporting on concurrently administered measures. This can be of particular value when such measures lack validity indicators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychological Sciences, Kent State University 600 Hilltop Drive, Kent, OH, United States.
- Neurobehavioural Associates, Neurobehavioural Associates Inc. 18945 - 111 Ave NW Edmonton, AB. T5S 2X4, Canada.
- Department of Educational Psychology, University of Alberta, 116 St and 85 Ave Edmonton, AB T6G 2R3, Canada.
ORCID-Profile: Kaci F Holmes, Megan R Whitman, Roger O Gervais, Yossef S Ben-Porath
Förderung
- University of Minnesota Press
Zitieren
APA
Holmes, K. F., Whitman, M. R., Gervais, R. O., & Ben-Porath, Y. S. (2025). Do MMPI-3 Validity Scale Findings Generalize to Concurrently Administered Measures? Validation with a Forensic Disability Sample. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acae093
Vancouver
Holmes KF, Whitman MR, Gervais RO, Ben-Porath YS. Do MMPI-3 Validity Scale Findings Generalize to Concurrently Administered Measures? Validation with a Forensic Disability Sample. Archives of Clinical Neuropsychology. 2025. doi:10.1093/arclin/acae093
BibTeX
@article{Holmes2025,
author = {Holmes, Kaci F and Whitman, Megan R and Gervais, Roger O and Ben-Porath, Yossef S},
title = {Do MMPI-3 Validity Scale Findings Generalize to Concurrently Administered Measures? Validation with a Forensic Disability Sample},
journal = {Archives of Clinical Neuropsychology},
year = {2025},
doi = {10.1093/arclin/acae093}
}
EUVIMED